SCHEMBL7464188

SCHEMBL7464188

Cc1ccccc1/C=C1\SC(=O)NC1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 3/20 1.00
NAT1 P18440 2/20 0.72
IGF1R P08069 2/20 0.67
GSK3B P49841 1/20 0.66
MEN1 O00255 6/20 0.63
KMT2A Q03164 6/20 0.63
AKR1B1 P15121 2/20 0.63
PIM1 P11309 4/20 0.62
PIM2 Q9P1W9 4/20 0.62
PIM3 Q86V86 2/20 0.62
HPGD P15428 3/20 0.60
TDP2 O95551 1/20 0.60
CASP7 P55210 1/20 0.60
CASP9 P55211 1/20 0.60
CASP6 P55212 1/20 0.60
CASP8 Q14790 1/20 0.60
ALDH1A1 P00352 4/20 0.55
PLA2G1B P04054 2/20 0.55
POLB P06746 2/20 0.55
HTT P42858 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13724876 1.00 TTR (1.00) TTRNAT1IGF1RGSK3BMEN1
SCHEMBL15091770 1.00 TTR (1.00) TTRNAT1IGF1RGSK3BMEN1
SCHEMBL9573270 0.84 NAT1 (1.00) TTRNAT1GSK3BMEN1KMT2A
SCHEMBL8182122 0.84 TTR (0.72) TTRNAT1IGF1RGSK3BMEN1
SCHEMBL9573277 0.84 NAT1 (1.00) TTRNAT1GSK3BMEN1KMT2A
SCHEMBL8182119 0.84 TTR (0.72) TTRNAT1IGF1RGSK3BMEN1
SCHEMBL1247451 0.81 TTR (0.68) TTRNAT1IGF1RGSK3BMEN1
SCHEMBL1247452 0.81 TTR (0.68) TTRNAT1IGF1RGSK3BMEN1
SCHEMBL6651682 0.81 TTR (0.69) TTRNAT1IGF1RGSK3BMEN1
SCHEMBL1249066 0.81 TTR (0.69) TTRIGF1RGSK3BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP claimed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO claimed
US-20230105307-A1 Identification of Stabilizers of Multimeric Proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2023-04-06 US disclosed
US-11337935-B2 Identification of stabilizers of multimeric proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2022-05-24 US disclosed
US-20200016098-A1 Identification of Stabilizers of Multimeric Proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2020-01-16 US disclosed
US-10278929-B2 Identification of stabilizers of multimeric proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2019-05-07 US disclosed
US-20190054040-A1 Identification of Stabilizers of Multimeric Proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2019-02-21 US disclosed
US-10039726-B2 Identification of stabilizers of multimeric proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2018-08-07 US disclosed
US-10039726-B2 Identification of stabilizers of multimeric proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2018-08-07 US disclosed
US-20160374961-A1 Identification of Stabilizers of Multimeric Proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2016-12-29 US disclosed
US-9308209-B2 Identification of stabilizers of multimeric proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO (US) 2016-04-12 US disclosed
US-8790855-B2 Charge control agent and toner using same HODOGAYA CHEMICAL CO., LTD (JP) 2014-07-29 US disclosed
US-8790855-B2 Charge control agent and toner using same HODOGAYA CHEMICAL CO., LTD (JP) 2014-07-29 US disclosed
US-20130203777-A1 Identification of Stabilizers of Multimeric Proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2013-08-08 US disclosed
US-20130203777-A1 Identification of Stabilizers of Multimeric Proteins THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2013-08-08 US disclosed
US-20130177843-A1 CHARGE CONTROL AGENT AND TONER USING SAME HODOGAYA CHEMICAL CO., LTD. (JP) 2013-07-11 US disclosed
US-20130177843-A1 CHARGE CONTROL AGENT AND TONER USING SAME HODOGAYA CHEMICAL CO., LTD. (JP) 2013-07-11 US disclosed
WO-2011140333-A1 IDENTIFICATION OF STABILIZERS OF MULTIMERIC PROTEINS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2011-11-10 WO disclosed
US-7872027-B2 Low molecular weight Myc-max inhibitors UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-01-18 US disclosed
US-20070203188-A1 oncoprotein gene expression inhibitors such as 5-[(4-chlorophenyl)methylidene]-3-(piperidin-1-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one, used as antiproliferative and anticarcinogenic agents UNIVERSITY OF PITTSBURGH (US) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230105307-A1 Identification of Stabilizers of Multimeric Proteins TTR, HSPBP1, HSPH1 TTR 1/4885NAT1 2461/4885IGF1R 2820/4885
US-20190054040-A1 Identification of Stabilizers of Multimeric Proteins TTR, HSPBP1, HSPH1 TTR 1/4885NAT1 2461/4885IGF1R 2820/4885
US-10278929-B2 Identification of stabilizers of multimeric proteins TTR, HSPBP1, HSPH1 TTR 1/4885NAT1 2389/4885IGF1R 2883/4885
US-11337935-B2 Identification of stabilizers of multimeric proteins TTR, HSPBP1, HSPH1 TTR 1/4885NAT1 2461/4885IGF1R 2820/4885
US-20160374961-A1 Identification of Stabilizers of Multimeric Proteins TTR, ALB, HSPBP1 TTR 1/4885NAT1 2241/4885IGF1R 3378/4885
US-10039726-B2 Identification of stabilizers of multimeric proteins TTR, ALB, HSPBP1 TTR 1/4885NAT1 2241/4885IGF1R 3378/4885
US-20070203188-A1 oncoprotein gene expression inhibitors such as 5-[(4-chlorophenyl)methylidene]-3-(piperidin-1-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one, used as antiproliferative and anticarcinogenic agents MYC, MYCBP, MAX TTR 3879/4885NAT1 1443/4885IGF1R 1652/4885
US-20130203777-A1 Identification of Stabilizers of Multimeric Proteins TTR, HSPBP1, HSP90B1 TTR 1/4885NAT1 2427/4885IGF1R 2618/4885
US-20200016098-A1 Identification of Stabilizers of Multimeric Proteins TTR, HSPBP1, HSPH1 TTR 1/4885NAT1 2461/4885IGF1R 2820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.